ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Growth Hormone
Phase 3

GHRP-2

GHRP-2

Also known as: Pralmorelin, KP-102, D-Ala-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2

Overview

Key Facts

Primary Goal: A synthetic hexapeptide GH secretagogue considered the most potent in the GHRP family

A synthetic hexapeptide GH secretagogue considered the most potent in the GHRP family. It produces strong GH release through the ghrelin receptor with moderate effects on appetite, cortisol, and prolactin, falling between GHRP-6 and ipamorelin in selectivity. Half-Life 15-60 minutes Typical Dose 100–300 mcg Frequency 2-3 times daily Cycle Length 8-16 weeks

Dosing Information

Half-Life

15-60 minutes

Typical Dose

100–300 mcg

Frequency

2-3 times daily

Cycle Length

8-16 weeks

Administration Routes:

subcutaneousintravenous

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F) or -20°C (-4°F) for long-term
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2-4 weeks

Note: Protect from light. Do not freeze reconstituted solution.

Research Summary

Phase 3

GHRP-2 (Pralmorelin) has been approved in Japan as a diagnostic agent for GH deficiency and extensively studied in clinical settings. Research demonstrates it produces the highest peak GH levels among GHRPs, approximately 20-40% greater than GHRP-6. Studies also suggest neuroprotective effects in models of neurodegeneration.

Frequently Asked Questions

Common questions about GHRP-2

UK-Specific Information

Exclusive data points and guidance for UK residents using GHRP-2

UK Lab Testing

US Lab Testing

Recommended labs: Quest Diagnostics, LabCorp ($120-$200 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With